Loading…
Based on limited metadata with no full letter text available, Paradigm RE LLC, a drug manufacturer or distributor, received an FDA Warning Letter on December 7, 2020. While the specific violations cannot be determined due to unavailable subject line details, the letter indicates regulatory concerns with the company's drug products or manufacturing practices. The warning was issued under FDA's drug regulatory authority, though the specific issuing office and exact violation count are not documented in the available metadata.